English

More about this topic

Health news

Teens on anti-obesity drugs less likely to consider or attempt suicide

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.

Health news

France to patients: Take weight loss drug Wegovy on your own dime

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Health news

UK toddlers get nearly half their calories from ultra-processed foods

Children who ate the most ultra-processed foods as toddlers were more likely to continue eating them by age seven, the study found.

Health news

Why are European girls starting puberty earlier than before?

Researchers have some promising leads but no definite answers as to why girls are entering early puberty more frequently than in the past.

ADVERTISEMENT

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

Health news

Severe obesity is rising in the US, according to new research

The rate of severe obesity is about 40 per cent in the US, with women at particularly high risk of severe obesity, the study found.

Health news

Women on weight loss drug lose more weight than men, study finds

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced higher rates of side effects like nausea and vomiting.

Health news

Weight-loss drug 'safe and effective' for kids as young as 6

Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as young as 12.

Health news

Inside Norway’s plan to ban unhealthy food ads that target teens

A Norwegian proposal to ban unhealthy food advertisements doesn’t go as far as the UK’s rule but pushes far beyond other European countries’ efforts.

Health news

Exposure to 'forever chemicals' during pregnancy tied to obesity risks

Women exposed to higher PFAS levels during pregnancy could face health complications later on, a new study says.

Health news

Using food delivery apps linked to obesity risk and lower-level jobs

Could how you purchase food online be linked to your social position and likelihood of obesity? New research from the UK suggests it might be.

Health news

Sugary drink intake up 23% globally since 1990, study finds

Global intake of sugar-sweetened beverages has risen alongside child obesity in recent decades, with the highest consumption levels in Latin America and the Middle East and North Africa.

Business

Investors look to weight loss drugs to boost Novo Nordisk growth

Novo Nordisk is releasing its second-quarter earnings on Wednesday, with analysts expecting more than 20% growth driven by Ozempic and Wegovy sales. However, the company faces challenges from more competition.

Health news

Weight loss drug may cut heart failure risk, company says

New results from a clinical trial evaluating the drug showed positive results for reducing heart failure risk.

Business

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

Health news

UK sugar tax slashed children's added sugar intake by half

Many soft drink manufacturers reformulated their products after the tax was announced in 2016, helping to reduce kids’ added sugar consumption over the next three years.

Business

Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

Health news

Popular obesity drug may help treat sleep apnoea

The drug tirzepatide is marketed as Mounjaro and Zepbound by pharmaceutical company Eli Lilly and belongs to the same class of drugs as semaglutide.

Health news

Global health authorities issue warning about fake Ozempic

A new global warning was issued over falsified versions of a popular weight-loss and type 2 diabetes drug.

Health news

Girls are experiencing earlier and more irregular periods, study says

A recent study found that girls are starting menstruation earlier and experiencing more irregular cycles, which could be influenced by factors like obesity and environmental chemicals.